CRISPR and Cancer: A New Way to Fight Back
Sat Nov 29 2025
Cancer is tricky. It finds ways to hide from the body's defense system. One way it does this is by using something called PD-1 and PD-L1. These are like secret handshakes that tell the immune system to back off. This makes it hard for treatments to work well.
Scientists have a new tool called CRISPR. It's like a tiny pair of scissors that can cut out specific parts of DNA. They're using it to snip out the PD-1 or PD-L1 parts in immune cells. This makes the cells better at fighting cancer. Tests on mice show it works. The treated cells grow better, make more fighting signals, and are better at killing cancer cells.
There's more. Scientists are also using CRISPR to change cancer cells themselves. By cutting out PD-L1 in these cells, they make the cancer easier to spot and attack. This can make other treatments work better too.
But it's not all smooth sailing. There are still problems to solve. Like making sure CRISPR cuts the right parts of DNA and gets to the right cells. Also, how long the changes last and if they're safe.
Right now, early tests on people show it's possible and safe. But there's still a lot to learn. Scientists are working hard to make this a real treatment for cancer.
https://localnews.ai/article/crispr-and-cancer-a-new-way-to-fight-back-5421229f
continue reading...
questions
How do preclinical studies comparing CRISPR-mediated PD-1 knockout in primary human T cells and TILs inform the potential clinical applications?
What are the primary mechanisms by which tumor heterogeneity can limit the effectiveness of CRISPR-Cas9 genome editing in targeting PD-1 or PD-L1?
How do acquired resistance and T-cell exhaustion specifically impact the long-term efficacy of CRISPR-mediated PD-1 inhibition in cancer treatment?
actions
flag content